MELAS Syndrome Pathophysiology

Genetic and Biochemical Characteristics

• The American Heart Association notes that the A3243G mutation in mitochondrial DNA is the most common cause of MELAS, present in approximately 80% of patients 1, 2
• This mutation occurs in the tRNA leucine gene, affecting mitochondrial protein synthesis, as reported by the American Diabetes Association 3

Clinical Manifestations

• The American College of Cardiology recommends considering MELAS in patients with stroke-like episodes that do not conform to specific arterial territories, as well as intolerance to exercise and onset before the age of 40 2
• The American Academy of Neurology notes that MELAS patients may present with seizures, "ragged-red" muscle fibers, migraines, and multisystemic manifestations, including cardiac conduction defects, diabetes mellitus, short stature, myopathy, and gastrointestinal disorders 2

Therapeutic Options

• The American Heart Association suggests that L-arginina, a precursor to nitric oxide, may improve endothelial function through flow-mediated vasodilation 1, 2
• The American College of Cardiology recommends considering idebenona, a synthetic analogue of coenzyme Q10, as well as vitamin C, which supports mitochondrial function as an antioxidant 2
• The American Academy of Neurology notes that dicloroacetato may help reduce lactic acid levels 2

Diagnostic Considerations

• The American Academy of Otolaryngology-Head and Neck Surgery reports that MELAS may present with sudden bilateral hearing loss, confusion, elevated serum lactic acid levels, stroke-like episodes, migraines, seizures, and diabetes 4
• The American Heart Association recommends differentiating MELAS from other causes of stroke in young individuals, such as transient cerebral arteriopathy, central nervous system vasculitis, and Fabry disease, as well as other mitochondrial disorders and metabolic diseases 5, 3

Clinical Manifestations of MELAS Syndrome

Neurological Manifestations

• The American Academy of Otolaryngology-Head and Neck Surgery reports that patients with MELAS syndrome may experience bilateral and sudden neurosensory hearing loss 6

Cardiovascular Manifestations

• According to the American College of Medical Genetics and Genomics, patients with MELAS syndrome are at risk of developing pulmonary hypertension 7

Management of MELAS Syndrome with L-Arginine Therapy

Primary Treatment Approach

• L-arginine therapy is the primary management approach for patients with MELAS syndrome, as it may extend the interictal phase of stroke-like episodes and improve acute symptoms including headache, nausea/vomiting, impaired consciousness, and visual disturbances 8
• For acute stroke-like episodes, intravenous L-arginine may improve headache, nausea/vomiting, impaired consciousness, and visual disturbances, but may result in fevers and lower hemoglobin 8
• For prevention of stroke-like episodes, oral L-arginine may extend the interictal phase of stroke-like spells, with dosage and duration requiring individualization 8

Diagnostic Considerations

• Bilateral sudden hearing loss with elevated lactate levels should raise suspicion for MELAS, according to the American Academy of Otolaryngology-Head and Neck Surgery 9

Knowledge Gaps and Limitations

• Optimal dosage, timing of initiation, and duration of L-arginine therapy remain to be established through randomized controlled trials, as stated by the American Heart Association/Stroke journal 8
• L-citrulline raises nitric oxide production more than L-arginine but has not been systematically studied in humans with MELAS, according to the American Heart Association/Stroke journal 8
• The rare nature of MELAS makes generating high-quality evidence for therapies challenging, as noted by the American Heart Association/Stroke journal 8

Mitochondrial DNA Inheritance and Disease Expression in MELAS Syndrome

Inheritance Pattern and Disease Severity

• The proportion of mutant versus normal mitochondrial DNA (heteroplasmy level) inherited from the mother determines the severity of disease in an affected male child, with high-energy organs being most vulnerable 10
• The threshold effect, where clinical manifestations emerge when mutant mtDNA exceeds a critical percentage, plays a crucial role in disease expression 10

Genetic Counseling and Reproductive Considerations

• Women with MELAS mutations face significant reproductive counseling challenges, and newer mitochondrial replacement techniques (MRTs) involving transfer of nuclear genetic material into donor oocytes with healthy mitochondria are being developed, though currently only permitted in the UK 11

Carbon Dioxide Delta 10 in MELAS Syndrome

Understanding the Condition

• Normal PaCO2 range is 34-46 mmHg, and a "delta 10" suggests a PaCO2 approximately 10 mmHg elevated above the upper limit of normal, indicating moderate hypercapnia 12
• In MELAS patients with seizures, elevated CO2 can indicate inadequate ventilation or worsening metabolic acidosis with inadequate respiratory compensation 13

Critical Significance in MELAS Syndrome

• Seizures are a cardinal feature of MELAS and can occur at any age, with elevated serum and CSF lactic acid levels being diagnostic hallmarks 13
• Primary respiratory acidosis can occur due to hypoventilation from seizure, CNS depression, or respiratory muscle weakness, characterized by pH <7.35 with elevated PaCO2 and normal or slightly elevated bicarbonate 14

Urgent Management Algorithm

• If the patient is actively seizing or has depressed consciousness, intubation and mechanical ventilation may be required to normalize PaCO2 and prevent further neurologic deterioration, with aggressive antiepileptic drug intervention required for seizure control in MELAS 14
• The American Thoracic Society recommends measuring serum lactate immediately, as this is the hallmark metabolic derangement in MELAS, and considering intravenous sodium bicarbonate for severe acidosis 12

Critical Pitfalls to Avoid

• The elevated CO2 in MELAS is rarely just a ventilation problem, but typically reflects the body's inability to compensate for severe metabolic acidosis due to mitochondrial dysfunction, according to the European Respiratory Society 14
• MELAS patients with hypoxemia should receive adequate oxygen, as the mechanism of CO2 retention is fundamentally different from COPD patients, with the American College of Chest Physicians recommending oxygen therapy in these cases 12, 14

Management of MELAS Syndrome During Infections

Clinical Management

• The American Academy of Pediatrics recommends aggressive hydration with fluids, antipyretics for fever, and rest to avoid physical exertion in patients with MELAS syndrome during mild infections 15
• The Infectious Diseases Society of America suggests considering prophylactic antibiotics in children with chronic comorbid diseases, including MELAS, who develop high fever and respiratory symptoms 15
• The European Society of Pediatric Neurology recommends monitoring for signs of stroke-like episodes, altered consciousness, and respiratory distress, and seeking immediate medical attention if these symptoms occur 15
• The American College of Emergency Physicians advises providing adequate oxygen if hypoxemia develops, as the mechanism of respiratory compromise in MELAS is fundamentally different from COPD 15

Diagnostic Evaluation

• The American Academy of Neurology recommends checking serum lactate levels if symptoms worsen, as elevated serum and CSF lactic acid levels are diagnostic hallmarks of MELAS 15

Treatment

• The Mitochondrial Medicine Society recommends L-arginine therapy as the primary treatment for preventing and managing stroke-like episodes in MELAS patients, with a dosage of 600 mg/kg/day for patients under 20 kg or 12 g/m² for patients over 20 kg 15